A density functional study of the hydrogen-bond network within the HIV-1 protease catalytic site cleft

被引:9
作者
Sirois, S
Proynov, EI
Truchon, JF
Tsoukas, CM
Salahub, DR
机构
[1] Ctr Rech Calcul Appl CERCA, Montreal, PQ H3X 2H9, Canada
[2] Univ Montreal, Dept Chim, Montreal, PQ H3C 3J7, Canada
[3] Montreal Gen Hosp, Montreal, PQ H3G 1A4, Canada
关键词
DFT; HIV protease; protonation states; model size importance;
D O I
10.1002/jcc.10176
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The relative energy between two different protonation sites of the Asp25' catalytic site residue is computed and analyzed for various HIV-1 Protease/inhibitor complexes and compared to the wild-type structure. By comparing calculations of negatively charged fragments of gradually increasing size up to 105 atoms we show that correct modeling of the HIV-1 Protease active site requires much larger models than the commonly used acetic acid/acetate moieties. The energy difference between the two proposed protonation sites decreases as the size of the system increases and tends to converge only when the entire catalytic triad of both monomers is taken into account. The importance of the Gly27 backbone amine groups in the stabilization of the negative charge within the catalytic site cleft is revealed. Comparison of the wild-type structure with the structures from various Pr/drug complexes indicates that the HIV-1 protease has a particular catalytic site flexibility. (C) 2003 Wiley Periodicals, Inc. J Comput Chem 24: 1110-1119, 2003.
引用
收藏
页码:1110 / 1119
页数:10
相关论文
共 48 条
[1]  
[Anonymous], ADV QUANTUM CHEM, DOI DOI 10.1016/S0065-3276(08)60568-7
[2]   STRUCTURE OF HIV-1 PROTEASE WITH KNI-272, A TIGHT-BINDING TRANSITION-STATE ANALOG CONTAINING ALLOPHENYLNORSTATINE [J].
BALDWIN, ET ;
BHAT, TN ;
GULNIK, S ;
LIU, BS ;
TOPOL, IA ;
KISO, Y ;
MIMOTO, T ;
MITSUYA, H ;
ERICKSON, JW .
STRUCTURE, 1995, 3 (06) :581-590
[3]   PROTEIN DATA BANK - COMPUTER-BASED ARCHIVAL FILE FOR MACROMOLECULAR STRUCTURES [J].
BERNSTEIN, FC ;
KOETZLE, TF ;
WILLIAMS, GJB ;
MEYER, EF ;
BRICE, MD ;
RODGERS, JR ;
KENNARD, O ;
SHIMANOUCHI, T ;
TASUMI, M .
JOURNAL OF MOLECULAR BIOLOGY, 1977, 112 (03) :535-542
[4]   A QUANTUM-MECHANICAL STUDY OF THE ACTIVE-SITE OF ASPARTIC PROTEINASES [J].
BEVERIDGE, AJ ;
HEYWOOD, GC .
BIOCHEMISTRY, 1993, 32 (13) :3325-3333
[5]  
*BIOS TECHN, 1992, DEMON US GUID VERS 1
[6]   RETROVIRAL PROTEINASES - A 2ND FRONT AGAINST AIDS [J].
BLUNDELL, T ;
PEARL, L .
NATURE, 1989, 337 (6208) :596-597
[7]   Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus [J].
Borrow, P ;
Lewicki, H ;
Wei, XP ;
Horwitz, MS ;
Peffer, N ;
Meyers, H ;
Nelson, JA ;
Gairin, JE ;
Hahn, BH ;
Oldstone, MBA ;
Shaw, GM .
NATURE MEDICINE, 1997, 3 (02) :205-211
[8]  
CHEN ZG, 1994, J BIOL CHEM, V269, P26344
[9]   AIDS therapy - Failure isn't what it used to be ... but neither is success [J].
Cohen, J .
SCIENCE, 1998, 279 (5354) :1133-1134
[10]   IN-VIVO EMERGENCE OF HIV-1 VARIANTS RESISTANT TO MULTIPLE PROTEASE INHIBITORS [J].
CONDRA, JH ;
SCHLEIF, WA ;
BLAHY, OM ;
GABRYELSKI, LJ ;
GRAHAM, DJ ;
QUINTERO, JC ;
RHODES, A ;
ROBBINS, HL ;
ROTH, E ;
SHIVAPRAKASH, M ;
TITUS, D ;
YANG, T ;
TEPPLER, H ;
SQUIRES, KE ;
DEUTSCH, PJ ;
EMINI, EA .
NATURE, 1995, 374 (6522) :569-571